In Vitro and In Vivo Induction of Fetal Hemoglobin with a Reversible and Selective DNMT1 Inhibitor

The authors reported the discovery of a novel class of orally bioavailable DNA methyltransferase (DNMT1)-selective inhibitors as exemplified by GSK3482364.